Şunu aradınız:: veikli��sias (Litvanca - İngilizce)

didžiau-sias amžius
maximum age

rotblat perm sias funkcijas is dr.
rotblat took over from dr.

pranesta apie sias nepageidaujamas reakcijas:
the following adverse reactions were reported:

sitikinkite, kad turite sias detales:
make sure you have the following items:

sias reakcijas gali prireikti tuojau pat gydyti.
these reactions may require treatment right away.

galimi salutiniai poveikiai suskirstyti sias kategorijas:
possible side effects are listed according to the following categories:

sias reakcijas dazniausiai galima susilpninti sumazinus levodopos doz.
these reactions can usually be diminished by levodopa dosage reduction.

prasom sias instrukcijas atidziai perskaityti ir j nuosekliai laikytis.
please read the instructions carefully and follow them step by step.

sias plvele dengtas tabletes galima vartoti valgio metu arba nevalgius.
the film-coated tablets can be taken with or without food.

pries naudojant levemir innolet, prasome atidziai perskaityti sias instrukcijas.
please read the following instructions carefully before using your levemir innolet.

injekcijos vietos pasirinktame plote nuolatinis keitimas galt padti isvengti ar susvelninti sias reakcijas.
continuous rotation of the injection site within a given area may help to reduce or prevent these reactions.

remiantis nateglinido ir kit hipoglikemini vaist vartojimo patirtimi, galima nurodyti sias nepageidaujamas reakcijas.
based on the experience with nateglinide and with other hypoglycaemic agents, the following adverse reactions have been seen.

12 geriamasis tirpalas sveikiems asmenims yra bioekvivalentiski, todl sias farmacines formas galima keisti vien kita.
the tablet and oral solution were bioequivalent in healthy subjects; therefore, both forms may be used interchangeably.

juk sakoma, kad „kartojimas – tai pats nuoširdžiau-sias pagyrimas!“
as they say, ‘imitation is the sincerest formof flattery!’

2006 m. gyvendinant zmonms skirt vaist pradin vertinim, ketinama sutelkti dmes sias keturias pagrindines sritis:
initial evaluationhighlights in 2006 for initial evaluation of medicines for human use are expected in four main areas:

siekdama skatinti inovacijas ir mokslinius tyrimus, kurie padeda gerinti vaist kokyb --ir palengvinti vaist gavim --agentra imsis vairios veiklos ir taikys sias priemones:
in order to support innovation and research that leads to improved availability of medicines --and to promote access to them --the agency will conduct a range of activities and implement a variety of tools, as follows: